This trial is studying whether the drug Ketorolac can help reduce symptoms related to stents.
3 Primary · 0 Secondary · Reporting Duration: 1 to 2 months post stent removal
Active Control
Non-Treatment Group
36 Total Participants · 2 Treatment Groups
Primary Treatment: Intervention Group - Ketorlac (NSAID) · Has Placebo Group · Phase < 1
Age 18+ · All Participants · 2 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: